CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a large drop in short interest in October. As of October 31st, there was short interest totalling 7,500 shares, a drop of 11.8% from the October 15th total of 8,500 shares. Based on an average trading volume of 280,100 shares, the days-to-cover ratio is presently 0.0 days.

CNBX Pharmaceuticals Price Performance

Shares of OTCMKTS:CNBX remained flat at $0.01 during mid-day trading on Friday. The company had a trading volume of 838 shares, compared to its average volume of 187,155. The firm’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.01. CNBX Pharmaceuticals has a one year low of $0.01 and a one year high of $0.02.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.